UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ending March 31, 2012
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 0-11102
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in its charter)
| Florida | 59-1564329 | |
| (State Or Other Jurisdiction Of Incorporation Or Organization) | (I.R.S. Employer Identification No.) |
4041 SW 47 AVENUE
FORT LAUDERDALE, FLORIDA 33314
(Address of principal executive offices)
954-587-6280
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer ¨ |
| Non-accelerated filer ¨ | Smaller reporting companyx |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x
At May 15, 2012, 8,106,886 shares of the registrant’s Common Stock were outstanding.
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
TABLE OF CONTENTS
| Page | ||
| PART I | Financial Information: | |
| Item 1. Financial Statements | ||
| Condensed consolidated balance sheets at | 3 | |
| March 31, 2012 (unaudited) and December 31, 2011 | ||
| Condensed consolidated statements of operations (unaudited) for the | 4 | |
| three months ended March 31, 2012 and 2011 | ||
| Condensed consolidated statements of comprehensive income (unaudited) for the | 5 | |
| three months ended March 31, 2012 and 2011 | ||
| Condensed consolidated statements of cash flows (unaudited) for the | 6 | |
| three months ended March 31, 2012 and 2011 | ||
| Notes to condensed consolidated financial statements | 7-12 | |
| Item 2. Management’s Discussion and Analysis of Financial Condition | 12-16 | |
| and Results of Operations | ||
| Item 3. Quantitative and Qualitative Disclosures about Market Risk | 16 | |
| Item 4. Controls and Procedures | 16 | |
| PART II | Other Information: | |
| Item 1A. Risk Factors | 16 | |
| Item 6. Exhibits | 17 | |
| Signatures | 18 |
| 2 |
PART 1-FINANCIAL INFORMATION
Item 1.-Financial Statements
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2012 | December 31, 2011 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash | $ | 684,907 | $ | 585,357 | ||||
| Trade accounts receivable net of allowance for doubtful accounts of approximately $78,000 and $75,000 at March 31, 2012 and December 31, 2011, respectively | 3,050,892 | 2,563,089 | ||||||
| Receivables due from affiliated companies | 346,157 | 495,130 | ||||||
| Inventories, net | 9,934,712 | 9,627,798 | ||||||
| Prepaid expenses and other current assets | 446,651 | 424,168 | ||||||
| Deferred tax asset | 90,600 | 65,797 | ||||||
| Total Current Assets | 14,553,919 | 13,761,339 | ||||||
| Property, plant and equipment, net | 5,141,191 | 5,213,333 | ||||||
| Other Assets: | ||||||||
| Trademarks, trade names and patents, net | 857,780 | 870,642 | ||||||
| Other assets | 28,475 | 33,442 | ||||||
| Total Other Assets | 886,255 | 904,084 | ||||||
| Total Assets | $ | 20,581,365 | $ | 19,878,756 | ||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable – trade | $ | 1,321,223 | $ | 1,162,143 | ||||
| Revolving line of credit | 1,550,000 | 850,000 | ||||||
| Current portion of long term debt | 401,006 | 400,430 | ||||||
| Income taxes payable | 210,908 | 353,608 | ||||||
| Accrued expenses payable | 576,899 | 889,444 | ||||||
| Total Current Liabilities | 4,060,036 | 3,655,625 | ||||||
| Deferred tax liability | 272,279 | 250,191 | ||||||
| Long term debt, less current portion | 1,838,623 | 1,939,362 | ||||||
| Total Liabilities | 6,170,938 | 5,845,178 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders' Equity: | ||||||||
| Common stock - $.01 par value, 10,000,000 shares authorized; 8,458,389 shares issued at March 31, 2012 and December 31, 2011, respectively | 84,584 | 84,584 | ||||||
| Additional paid in capital | 8,183,390 | 8,163,864 | ||||||
| Less cost of common stock in treasury, 351,503 shares at March 31, 2012 and December 31, 2011, respectively | (288,013 | ) | (288,013 | ) | ||||
| Foreign currency translation adjustment | (264,213 | ) | (268,084 | ) | ||||
| Retained earnings | 6,423,193 | 6,058,848 | ||||||
| Total Shareholders' Equity of Ocean Bio-Chem, Inc. | 14,138,941 | 13,751,199 | ||||||
| Noncontrolling interest | 271,486 | 282,379 | ||||||
| Total Shareholders' Equity | 14,410,427 | 14,033,578 | ||||||
| Total Liabilities and Shareholders' Equity | $ | 20,581,365 | $ | 19,878,756 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
| OCEAN BIO-CHEM, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (UNAUDITED) |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2012 | 2011 | |||||||
| Gross sales | $ | 6,301,349 | $ | 7,085,477 | ||||
| Less: discounts, returns, and allowances | 296,634 | 352,970 | ||||||
| Net sales | 6,004,715 | 6,732,507 | ||||||
| Cost of goods sold | 3,862,869 | 4,223,466 | ||||||
| Gross profit | 2,141,846 | 2,509,041 | ||||||
| Operating Expenses: | ||||||||
| Advertising and promotion | 465,597 | 372,968 | ||||||
| Selling and administrative | 1,055,593 | 1,102,920 | ||||||
| Total operating expenses | 1,521,190 | 1,475,888 | ||||||
| Operating income | 620,656 | 1,033,153 | ||||||
| Other income (expense) | ||||||||
| Interest expense | (27,675 | ) | (25,776 | ) | ||||
| Other income | 1,056 | 23,948 | ||||||
| Income before income taxes | 594,037 | 1,031,325 | ||||||
| Provision for income taxes | 240,585 | 403,616 | ||||||
| Net income | 353,452 | 627,709 | ||||||
| Loss attributable to noncontrolling interests | 10,893 | 20,592 | ||||||
| Net income attributable to Ocean Bio-Chem, Inc. | $ | 364,345 | $ | 648,301 | ||||
| Earnings per common share – basic | $ | 0.04 | $ | 0.08 | ||||
| Earnings per common share – diluted | $ | 0.04 | $ | 0.08 | ||||
| Weighted average shares - basic | 8,106,886 | 7,853,613 | ||||||
| Weighted average shares - diluted | 8,466,020 | 8,176,322 | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 4 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2012 | 2011 | |||||||
| Net Income | $ | 353,452 | $ | 627,709 | ||||
| Foreign currency translation adjustment | 3,871 | 3,453 | ||||||
| Comprehensive income | 357,323 | 631,162 | ||||||
| Comprehensive loss attributable to noncontrolling interests | 10,893 | 20,592 | ||||||
| Comprehensive income attributable to Ocean Bio-Chem, Inc. | $ | 368,216 | $ | 651,754 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 5 |
| OCEAN BIO-CHEM, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (UNAUDITED) |
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2012 | 2011 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 353,452 | $ | 627,709 | ||||
| Adjustments to reconcile net income to net cash used in operating activities | ||||||||
| Depreciation and amortization | 172,088 | 221,136 | ||||||
| Deferred income taxes | (2,715 | ) | - | |||||
| Stock based compensation | 18,923 | 23,217 | ||||||
| Other operating non-cash items | 28,704 | 2,128 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | (491,457 | ) | (812,938 | ) | ||||
| Inventories | (324,556 | ) | (2,806,298 | ) | ||||
| Other assets | 4,967 | 14,367 | ||||||
| Prepaid expenses and other current assets | (22,483 | ) | (30,871 | ) | ||||
| Receivables due from affiliated companies | 148,973 | 94,885 | ||||||
| Accounts payable and other accrued expenses | (296,165 | ) | 745,022 | |||||
| Net cash used in operating activities | (410,269 | ) | (1,921,643 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (90,242 | ) | (119,450 | ) | ||||
| Contributions from joint venture | - | 36,842 | ||||||
| Net cash used in investing activities | (90,242 | ) | (82,608 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Net borrowings under revolving line of credit | 700,000 | 3,150,000 | ||||||
| Repayments of notes payable related party | - | (471,950 | ) | |||||
| Payments on long-term debt | (100,163 | ) | (462,266 | ) | ||||
| Net cash provided by financing activities | 599,837 | 2,215,784 | ||||||
| Effect of exchange rates on cash | 224 | 2,055 | ||||||
| Net increase in cash | 99,550 | 213,588 | ||||||
| Cash at beginning of period | 585,357 | 615,044 | ||||||
| Cash at end of period | $ | 684,907 | $ | 828,632 | ||||
| Supplemental disclosure of cash transactions: | ||||||||
| Cash paid for interest during period | $ | 27,209 | $ | 34,646 | ||||
| Cash paid for income taxes during period | $ | 386,000 | $ | 611,000 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 6 |
OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| 1. | SUMMARY OF ACCOUNTING POLICIES |
Interim reporting
The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology LLC (“OdorStar”), a joint venture in which the Company has a controlling interest. All significant intercompany transactions and balances have been eliminated in consolidation. Certain prior-period data have been reclassified to conform to the current period presentation. Unless the context indicates otherwise, the terms “Company”, “we”, “our”, “us” or similar terms refer to Ocean Bio-Chem, Inc. and its subsidiaries.
The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the three months ended March 31, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.
The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.
Use of estimates
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions.
Subsequent events
The Company evaluates events through the date the financial statements are filed to determine whether such events require adjustment to or disclosure in the financial statements.
| 2. | RECENT ACCOUNTING PRONOUNCEMENTS |
There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended March 31, 2012 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows. Accounting pronouncements that became effective during the three months ended March 31, 2012 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.
| 7 |
| 3. | INVENTORIES |
The composition of inventories at March 31, 2012 and December 31, 2011 are as follows:
| March 31, 2012 | December 31, 2011 | |||||||
| Raw materials | $ | 4,101,074 | $ | 4,431,651 | ||||
| Finished goods | 6,127,983 | 5,472,850 | ||||||
| Inventories, gross | 10,229,057 | 9,904,501 | ||||||
| Inventory reserves | (294,345 | ) | (276,703 | ) | ||||
| Inventories, net | $ | 9,934,712 | $ | 9,627,798 | ||||
The inventory reserves shown in the table above reflect slow moving and obsolete inventory.
The Company operates a vendor managed inventory program with one of its customers to improve the promotion of the Company's products. The Company manages the inventory levels at this customer’s warehouses and recognizes revenue as the products are sold by the customer. The inventories managed at the customer’s warehouses amounted to approximately $494,000 and $570,000 at March 31, 2012 and December 31, 2011, respectively.
| 4. | PROPERTY, PLANT, & EQUIPMENT |
The Company’s property, plant and equipment consisted of the following at March 31, 2012 and December 31, 2011:
|
Estimate Useful Life |
March 31, 2012 |
December 31, 2011 |
|||||||
| Land | $ | 278,325 | $ | 278,325 | |||||
| Building and Improvements | 30 years | 4,454,792 | 4,445,924 | ||||||
| Manufacturing and warehouse equipment | 6-20 years | 7,689,633 | 7,632,398 | ||||||
| Office equipment and furniture | 3-5 years | 674,467 | 668,046 | ||||||
| Construction in process | 47,348 | 32,788 | |||||||
| Leasehold improvement | 10-15 years | 122,644 | 122,644 | ||||||
| Property, plant and equipment, gross | 13,267,209 | 13,180,125 | |||||||
| Less accumulated depreciation | (8,126,018) | (7,966,792) | |||||||
| Property, plant and equipment, net | $ | 5,141,191 | $ | 5,213,333 | |||||
| 5. | NONCONTROLLING INTEREST |
On May 10, 2010, the Company announced the formation of OdorStar Technology LLC, a joint venture between the Company and BBL Distributors, LLC. OdorStar owns patents that relate to a formula and delivery system, for use with products containing chlorine dioxide, designed to safely prevent and eliminate odors relating to mold, mildew and other sources of unpleasant odors. The Company and BBL Distributors, LLC share equally in profits or losses from OdorStar. Because the Company manages OdorStar, it has consolidated OdorStar in its financial statements. The Company’s condensed consolidated financial statements include $ 532,000 and $541,000 in assets and $5,000 and $6,000 in liabilities from OdorStar at March 31, 2012 and December 31, 2011, respectively. The Company’s condensed consolidated financial statements also include OdorStar’s operating losses of approximately $22,000 and $41,000 during the three months ended March 31, 2012 and 2011, respectively.
| 8 |
| 6. | REVOLVING LINE OF CREDIT |
On July 6, 2011, the Company, together with its subsidiary, Kinpak Inc. (“Kinpak”), entered into a Credit Agreement with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)). Under the Credit Agreement, the Company’s revolving line of credit with Regions Bank was renewed. The terms of the revolving line of credit, as renewed, provide that the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory. Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless the Company’s debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense) falls below 2.0 to 1, in which case the interest is payable at the 30 day LIBOR rate plus 2.75% per annum). In no event will the interest rate be less than 2.0% per annum. Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time. The Company’s obligations under the revolving line of credit are secured by the Company’s accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility. The Company’s obligations under the revolving line of credit and the term loan discussed in footnote 7 below are cross-collateralized. Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014. The Credit Agreement includes financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At March 31, 2012, the Company was in compliance with these covenants. The Company’s principal obligation under the revolving line of credit was $1,550,000 and $850,000 at March 31, 2012 and December 31, 2011, respectively. The interest rate was 2.0% per annum at March 31, 2012 and December 31, 2011.
| 7. | LONG TERM DEBT |
On July 6, 2011, under the Equipment Finance Addendum to the Credit Agreement, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%. Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures. The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment. At March 31, 2012, approximately $2,185,000 was outstanding under the term loan.
At March 31, 2012 and December 31, 2011, the Company was obligated under various capital lease agreements covering equipment utilized in the Company’s operations. The capital leases, aggregating $54,887 and $62,400 at March 31, 2012 and December 31, 2011, respectively, have varying maturities through 2015 and carry interest rates ranging from 7% to 14%.
The following table provides information regarding the Company’s long term debt at March 31, 2012 and December 31, 2011:
| Current Portion | Long Term Portion | |||||||||||||||
| March 31, 2012 | December 31, 2011 | March 31, 2012 | December 31, 2011 | |||||||||||||
| Term loan | 378,896 | 375,562 | 1,805,846 | 1,901,830 | ||||||||||||
| Capitalized equipment leases | 22,110 | 24,868 | 32,777 | 37,532 | ||||||||||||
| Total long term debt | $ | 401,006 | $ | 400,430 | $ | 1,838,623 | $ | 1,939,362 | ||||||||
| 9 |
Required principal payments under the Company’s long term obligations are set forth below:
| 12 month period ending March 31, | ||||
| 2013 | $ | 401,006 | ||
| 2014 | 409,964 | |||
| 2015 | 416,240 | |||
| 2016 | 427,036 | |||
| 2017 | 436,441 | |||
| Thereafter | 148,942 | |||
| Total | $ | 2,239,629 | ||
| 8. | RELATED PARTY TRANSACTIONS |
During the three months ended March 31, 2012 and 2011, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $227,000 and $430,000 during the three months ended March 31, 2012 and 2011, respectively, and administrative fees aggregated approximately $60,000 and $50,000 during the three months ended March 31, 2012 and 2011, respectively. The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $346,000 and $495,000 at March 31, 2012 and December 31, 2011, respectively. Transactions with the affiliated companies were made in the ordinary course of business but were not made on substantially the same terms and conditions as those prevailing at the same time for comparable transactions with other customers. Management believes that the sales transactions did not involve more than normal credit risk or present other unfavorable features.
A subsidiary of the Company currently uses the services of an entity that is owned by the Chairman, President and Chief Executive Officer of the Company to conduct product research and development. The Company paid the entity $10,500 for the three months ended March 2012 and 2011 under this arrangement.
The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. The Company believes that the rental payments are below market rates. See Note 9 for a description of the lease terms.
On December 6, 2010, the Company redeemed a warrant held by its Chairman, President and Chief Executive Officer to purchase 500,000 shares of its Common Stock at an exercise price of $0.836 per share. The warrant initially was issued to him in connection with financing he provided to the Company in December 2005. The aggregate redemption price of the warrant was $471,950, which was based on the difference between the closing price of the Company's Common Stock on December 6, 2010 and the exercise price of the warrant. The Company issued a note to the Chairman, President and Chief Executive Officer in an amount equal to the redemption price, which bore interest at the rate of 3% per annum. On January 5, 2011, the Company paid all outstanding principal and interest on the note. The redemption, which was approved by the independent directors of the Board of Directors, was effected in order to prevent the dilutive effect of the exercise of the warrant.
A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis. During the three months ended March 31, 2012 and 2011, the Company paid in aggregate of approximately $149,000 and $114,000, respectively in insurance premiums on policies obtained through the entity.
| 10 |
| 9. | COMMITMENTS |
The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. On May 1, 2008, the Company renewed the lease for a term of ten years. The lease requires annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into the lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party. Rent expense under the lease was $25,000 for the three months ended March 31, 2012 and 2011.
The Company leases from the Alabama State Port Authority a 1.5 acre docking facility on the Alabama River, located approximately eleven miles from the Company’s Alabama manufacturing facility. The lease expires on September 30, 2014, and requires the Company to pay rent and additional expenses totaling approximately $7,800 annually.
| 10. | EARNINGS PER SHARE |
Basic earnings per share is calculated based on net income attributable to Ocean Bio-Chem, Inc. and the weighted average number of shares outstanding during the reported period. Diluted earnings per share reflect additional dilution from potential common stock issuable upon the exercise of outstanding stock options. The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.
| Three Months Ended March 31, | ||||||||
| 2012 | 2011 | |||||||
| Earnings per common share –Basic | ||||||||
| Net income attributable to OBCI | $ | 364,345 | $ | 648,301 | ||||
| Weighted average number of common shares outstanding | 8,106,886 | 7,853,613 | ||||||
| Earnings per common share – Basic | $ | 0.04 | $ | 0.08 | ||||
| Earnings per common share – Diluted | ||||||||
| Net income attributable to OBCI | $ | 364,345 | $ | 648,301 | ||||
| Weighted average number of common shares outstanding | 8,106,886 | 7,853,613 | ||||||
| Effect of employee stock-based awards | 359,134 | 322,709 | ||||||
| Weighted average number of common shares outstanding - assuming dilution | 8,466,020 | 8,176,322 | ||||||
| Earnings per common share - Diluted | $ | 0.04 | $ | 0.08 | ||||
The Company had 0 and 27,500 stock options outstanding at March 31, 2012 and 2011, respectively, that were anti-dilutive and therefore not included in the diluted earnings per common share calculation because their effect would be anti-dilutive.
| 11 |
| 11. | SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS |
Stock compensation expense attributable to stock options was approximately $19,000 and $23,000 for the three months ended March 31, 2012 and 2011, respectively. There were no equity grants or awards issued during the three months ended March 31, 2012 and 2011.
At March 31, 2012, there was approximately $48,000 of unrecognized compensation expense related to options awarded to employees. This cost will be charged as compensation expense through 2013, as the options vest.
The following table provides information at March 31, 2012 regarding outstanding options under the Company’s stock option plans as well as a grant made outside of the Company’s stock option plans. As used in the table below, “2007 ISO” refers to the Company’s 2007 Incentive Stock Option Plan, “2008 ISO” refers to the Company’s 2008 Incentive Stock Option Plan, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.
| Plan | Date Granted | Options Outstanding | Exercisable Options | Exercise Price | Expiration Date | Weighted Average Remaining Life | ||||||||||||||
| Non Plan | 3/25/09 | 115,000 | 115,000 | $ | 0.55 | 3/24/14 | 2.0 | |||||||||||||
| 2007 ISO | 5/17/07 | 136,500 | 106,000 | 1.66 | 5/16/12 | 0.1 | ||||||||||||||
| 2007 ISO | 10/08/07 | 2,500 | 2,000 | 1.87 | 10/07/12 | 0.5 | ||||||||||||||
| 2007 ISO | 12/17/07 | 142,600 | 111,300 | 1.32 | 12/16/12 | 0.7 | ||||||||||||||
| 2008 ISO | 8/25/08 | 144,100 | 81,500 | 0.97 | 8/24/13 | 1.4 | ||||||||||||||
| 2002NQ | 10/22/02 | 30,000 | 30,000 | 1.26 | 10/21/12 | 0.6 | ||||||||||||||
| 2002NQ | 6/20/03 | 30,000 | 30,000 | 1.03 | 6/19/13 | 1.2 | ||||||||||||||
| 2002NQ | 5/25/04 | 30,000 | 30,000 | 1.46 | 5/24/14 | 2.2 | ||||||||||||||
| 2002NQ | 4/03/06 | 40,000 | 40,000 | 1.08 | 4/02/16 | 4.1 | ||||||||||||||
| 2002NQ | 12/17/07 | 50,000 | 50,000 | 1.32 | 12/16/17 | 5.8 | ||||||||||||||
| 2008NQ | 1/11/09 | 50,000 | 50,000 | 0.69 | 1/10/19 | 6.9 | ||||||||||||||
| 2008NQ | 4/26/10 | 25,000 | 25,000 | 2.07 | 4/25/20 | 8.2 | ||||||||||||||
| 795,700 | 670,800 | $ | 1.17 | 2.1 | ||||||||||||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking Statements:
Certain statements contained in this Quarterly Report on Form 10-Q, including without limitation, advertising and promotion expense, our ability to provide required capital to support inventory levels, the effect of price increases in petroleum-based or chemical-based raw materials on our margins, and the sufficiency of funds provided through operations and existing sources of financing to satisfy our cash requirements constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry, reliance on certain key customers, changes in consumer demand for marine, recreational vehicle and automotive products, advertising and promotional efforts, exposure to market risks relating to changes in interest rates and foreign exchange rates, and other factors.
| 12 |
Overview:
We are principally engaged in the manufacturing, marketing and distribution of a broad line of appearance and maintenance products for boats, recreational vehicles, automobiles and home care under the Star brite® and other trademarks within the United States of America and Canada. In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services of these and other products. We sell our products through national retailers and to national and regional distributors who, in turn, sell our products to specialized retail outlets.
Critical accounting estimates:
See “Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the year ended December 31, 2011 for information regarding the Company's critical accounting estimates.
Results of Operations:
Three Months Ended March 31, 2012 Compared to the Three Months Ended March 31, 2011
Net sales were approximately $6,005,000 for the three months ended March 31, 2012 compared to approximately $6,733,000 during the corresponding period in 2011, a decrease of $728,000 or 10.8%. We believe the sales decrease principally reflects a determination by some of our largest customers to curtail their first quarter purchases in order to reduce their inventory levels. In addition, the abnormally warm winter in the northern states limited use of snow mobiles, which we believe caused a reduction in sales of our fuel additive products in the recreational vehicle market.
Cost of goods sold and gross profit – Cost of goods sold during the three months ended March 31, 2012 decreased by approximately $360,000 or 8.5%, to approximately $3,863,000 from approximately $4,223,000 during the three months ended March 31, 2011. The decrease in cost of goods sold is directly related to the decrease in sales volume.
Our gross profit percentage (gross profit as a percentage of net sales) decreased by 1.6% in the first quarter of 2012 as compared to the same period in 2011. This decrease was primarily caused by lower production volume due to lower sales volume, resulting in a higher proportion of fixed costs as a percentage of sales. Gross profit decreased by approximately $367,000 for the three months ended March 31, 2012, as compared to the same period in 2011.
Advertising and promotion increased to approximately $466,000 for the three months ended March 31, 2012 from $373,000 during the corresponding period in 2011, an increase of approximately $93,000 or 24.8%. As a percentage of net sales, advertising and promotion expense increased from 5.5% in the first quarter of 2011 to 7.8% in the first quarter of 2012. The increase is primarily due to increased television advertising. Additionally, the Company developed a new co-op advertising program with one of its largest customers. The program increased gross sales, but the increases generally were offset by advertising allowances that we provided to the customer under the program. We anticipate that advertising and promotion expenses during the remainder of 2012 will continue to exceed 2011 levels.
Selling and administrative expenses decreased by approximately $47,000 or 4.3%, from approximately $1,103,000 during the three months ended March 31, 2011 to approximately $1,056,000 during the same period in 2012. The decrease is due to lower variable sales commissions and the cessation of our amortization of bank fees incurred in connection with a letter of credit we obtained to secure obligations under a lease agreement relating to industrial revenue bonds. The bonds, which were redeemed in July 2011, were used to fund expansion of our Kinpak, Inc. (“Kinpak”) subsidiary’s Montgomery, Alabama manufacturing facilities. Upon redemption of the bonds, we charged off all unamortized fees. As a percentage of net sales, selling and administrative expenses increased from 16.4% to 17.6%.
| 13 |
Interest expense increased by approximately $2,000 to $28,000 during the three months ended March 30, 2012, compared to approximately $26,000 during the three months ended March 31, 2011.
Operating income – As a result of the foregoing, operating income was approximately $621,000 in the first quarter of 2012 compared to approximately $1,033,000 in the 2011 period, a decrease of $412,000 or 39.9%.
Income taxes - The Company had income tax expense in the first quarter of 2012 of approximately $241,000, or 40.5% of pretax income, compared to $404,000, or 39.1% of pretax income, during the corresponding period in 2011.
Net income and Net income attributable to Ocean Bio-Chem, Inc. - As a result of the items mentioned above, net income for the first quarter of 2012 decreased by approximately $275,000, or 43.7%, to $353,000 from approximately $628,000 in the first quarter of 2011. Net income attributable to Ocean Bio-Chem. Inc. decreased by approximately $284,000, or 43.8%, to $364,000 in the first quarter 2012, from approximately $648,000 in 2011.
Liquidity and capital resources:
Our cash balance was approximately $685,000 at March 31, 2012 compared to approximately $585,000 at December 31, 2011. At March 31, 2012, we had $1,550,000 in short-term borrowings outstanding under our revolving line of credit compared to $850,000 outstanding at December 31, 2011. The increase in short term borrowings is primarily attributable to cash used for operations along with purchases of manufacturing and office equipment and long-term debt repayments.
Net cash used by operating activities during the three months ended March 31, 2012 was approximately $410,000 compared to approximately $1,922,000 for the three months ended March 31, 2011. The lower amount of net cash used in operating activities during the three months ended March 31, 2012 principally reflected much lower increases in inventory ($324,556 in the 2012 period compared to $2,806,298 in the 2011 period), offset in part by higher net income in the 2011 period. In the first quarter of 2011, we determined to build up our level of inventories in anticipation of higher prices for petroleum-based raw materials and to support higher levels of sales. The cash used in operating activities during the three months ended March 31, 2012 principally reflected an increase in accounts receivable of approximately $491,000, an increase in inventory of approximately $325,000, and a decrease in accounts payable and accrued expenses payable of approximately $296,000. The increase in accounts receivable reflects a higher level of sales in March 2012 as compared to earlier months in 2012. The cash used in operations were partially offset by net income of approximately $353,000, non-cash charges of $217,000, and a reduction in amounts due from affiliated companies of approximately $149,000. The principal non-cash charges were depreciation and amortization expense of approximately $172,000 and stock-based compensation expense of approximately $19,000.
Net cash used in investing activities was approximately $90,000 for the three months ended March 31, 2012 compared to approximately $83,000 for the three months ended March 31, 2011. In the 2012 period, the Company used approximately $90,000 to purchase manufacturing and office equipment.
Net cash provided by financing activities was approximately $600,000 for the three months ended March 31, 2012 compared to approximately $2,216,000 for the three months ended March 31, 2011. During the three months ended March 31, 2012, cash was provided through borrowings of $700,000 under our revolving line of credit, partially offset by payments on long term debt of approximately $100,000.
| 14 |
On July 6, 2011, Ocean Bio-Chem, Inc. and Kinpak entered into a credit agreement (the “Credit Agreement”) with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)) under which (a) our revolving line of credit with Regions Bank was renewed, and (b) REFCO provided a term loan to us in the amount of $2,430,000, the proceeds of which were used to pay Kinpak’s remaining lease obligations in connection with the 2002 Series of Industrial Development Revenue Bonds issued by the City of Montgomery, Alabama to fund the expansion of Kinpak’s facilities and acquisition of related equipment.
Under the new term loan, we are repaying the $2,430,000 principal amount, together with interest at the fixed rate of 3.54% per annum, in 72 consecutive monthly payments of $37,511 over the six year period beginning on August 6, 2011, with the final payment on July 6, 2017. In the event our debt service coverage ratio falls below 2.0 to 1, interest on the term loan will increase by 1.01% per annum.
The Credit Agreement defines “debt service coverage ratio“ as meaning net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense. The Credit Agreement contains various covenants, including financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At March 31, 2012, the Company was in compliance with these covenants.
Under the renewed revolving line of credit, we may borrow up to the lesser of (i) $6 million and (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory. Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless the Company’s debt service coverage ratio falls below 2.0 to 1, in which case interest will be payable at the 30 day LIBOR rate plus 2.75% per annum). In no event will the interest rate be less than 2.0% per annum. Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time. Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014.
The Company’s obligations under the Credit Agreement are secured by the our accounts receivable and inventory, as well as real property and equipment at the Kinpak’s Montgomery, Alabama facility.
In addition to the revolving line of credit and term loan, we have obtained financing through capital leases for both manufacturing and office equipment, totaling approximately $54,887 and $62,400 at March 31, 2012 and December 31, 2011, respectively.
We sell our products in the Canadian market and are subject to currency fluctuations relating to the Canadian dollar. We do not engage in currency hedging and address currency risk as a pricing issue. In the three months ended March 31, 2012, we recorded $3,871 in foreign currency translation adjustments (increasing shareholders’ equity by $3,871) as a result of the strengthening of the Canadian dollar in relation to the US dollar.
During the past few years, we have introduced a number of new products to our customers. At times, new product introductions have required us to increase our overall inventory and have resulted in lower inventory turnover rates. The effects of reduced inventory turnover have not been material to our overall operations. We believe that we can continue to provide, through our operations and financing arrangements, all required capital to support increased inventory levels.
Many of the raw materials that we use in the manufacturing process are petroleum-based or chemical-based and are subject to fluctuating prices. The nature of our business does not enable us to pass through the price increases to our national retailers and distributors as promptly as we experience increases in raw material costs. This may, at times, adversely affect our margins.
| 15 |
At March 31, 2012 and through the date of this report, we did not and do not have any material commitments for capital expenditures or inventories, nor do we have any other present commitment that is likely to result in our liquidity increasing or decreasing in any material way.
We believe that funds provided through operations and its existing sources of financing will be sufficient to satisfy its cash requirements over at least the next twelve months
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Not applicable
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures:
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.
Change in Internal Controls over Financial Reporting:
No change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1A. – Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, which could materially affect the Company’s business, financial condition or future results.
| 16 |
Item 6. – Exhibits
|
Exhibit No. |
Description | |
| 31.1 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. * | |
| 31.2 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. * | |
| 32.1 |
Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. * | |
| 32.2 |
Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. * | |
| 101 |
The following materials from Ocean Bio-Chem, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011, (ii) Condensed Consolidated Statements of Operations for the three months ended March 31, 2012 and 2011, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2012 and 2011; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and 2011 and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text. |
* Filed herewith.
| 17 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on behalf by the Undersigned there unto duly authorized.
| OCEAN BIO-CHEM, INC. | |
| Dated: May 15, 2012 | /s/ Peter G. Dornau |
| Peter G. Dornau | |
| Chairman of the Board, President and | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| /s/ Jeffrey S. Barocas | |
| Jeffrey S. Barocas | |
| Vice President | |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
| 18 |
EXHIBIT 31.1
CERTIFICATION
I, Peter G. Dornau certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Ocean Bio-Chem, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Dated: May 15, 2012 | /s/ Peter G. Dornau |
| Peter G. Dornau | |
| Chairman of the Board, President and | |
| Chief Executive Officer | |
| (Principal Executive Officer) |
EXHIBIT 31.2
CERTIFICATION
I, Jeffrey S. Barocas certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Ocean Bio-Chem, Inc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Dated: May 15, 2012 | /s/ Jeffrey S. Barocas |
| Jeffrey S. Barocas | |
| Vice President | |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO RULE 13a-14(b)
UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350
I, Peter G. Dornau, Chief Executive Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:
| 1. | The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| By: | /s/ Peter G. Dornau | |
Peter G. Dornau Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer) | ||
Dated: May 15, 2012
EXHIBIT 32.2
CERTIFICATION PURSUANT TO RULE 13a-14(b)
UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350
I, Jeffrey S. Barocas, Chief Financial Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:
| 1. | The Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| By: | /s/ Jeffrey S. Barocas | |
Jeffrey S. Barocas Vice President Chief Financial Officer (Principal Financial and Accounting Officer) | ||
Dated: May 15, 2012
|
INVENTORIES
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVENTORIES |
The compositionof inventories at March 31, 2012 and December 31, 2011 are as follows:
The inventory reserves shown in the table above reflect slow moving and obsolete inventory.
The Company operates a vendor managed inventory program with one of its customers to improve the promotion of the Company's products. The Company manages the inventory levels at this customer’s warehouses and recognizes revenue as the products are sold by the customer. The inventories managed at the customer’s warehouses amounted to approximately $494,000 and $570,000 at March 31, 2012 and December 31, 2011, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||